Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]PersonGen BioTherapeutics"
Count: 31
Selected: 0
NCT IDTitle
NCT05432401TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
NCT05190185A Clinical Trial of TAA06 Injection in Advanced Solid Tumors
NCT05170568PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
NCT05017883TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia
NCT04864821Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor
NCT04785833CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia
NCT04702841CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors
NCT04700319CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies
NCT04692948TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia
NCT04691349CAR-T for r/r Malignant Tumors in Children
NCT04480788CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study
NCT04439721γδT Cell Infusion to Prevent Relapsed/Refractory Leukemia Rescue Relapse
NCT04691713CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
NCT04650724Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor
NCT04004637CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia
NCT04237428CD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's Lymphoma
NCT04186052Clinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive r/r Multiple Myeloma
NCT04184414The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies
NCT03999697A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
NCT02944162CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML
NCT02892695PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma
NCT02839954CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
NCT02742727CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
NCT02617134CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
NCT02587689Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor
NCT02819583CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
NCT02851589Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
NCT05445011Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia
NCT04762485Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia
NCT05023707Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia
NCT05059912CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma